cyclic glycine-proline

a metabolite of insulin-like growth factor-1 (IGF-1)

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

1.	Stroke (Strokes) 04/01/2019 - "Plasma cyclic glycine proline/IGF-1 ratio predicts clinical outcome and recovery in stroke patients." 04/01/2019 - "This study evaluated plasma concentrations of IGF-1, IGF binding protein (IGFBP)-3 and cyclic-glycine-proline (cGP) and their associations with clinical outcome in stroke patients. "
2.	Amyloid Plaque 01/01/2023 - "Cyclic Glycine-Proline Improves Memory and Reduces Amyloid Plaque Load in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease."
3.	Gestational Diabetes (Gestational Diabetes Mellitus) 01/06/2020 - "Sex-specific interactions with maternal factors were observed, as the infant sex mediated associations between gestational diabetes and milk adiponectin (p = 0.031), birth-mode and total protein (p = 0.003), maternal education and insulin-like growth factor-1: cyclic Glycine-Proline ratio (p = 0.035). "
4.	Obesity 05/01/2018 - "The role for cyclic Glycine-Proline, a biological regulator of insulin-like growth factor-1 in pregnancy-related obesity and weight changes."
5.	Brain Injuries (Brain Injury) 03/17/2014 - "We have shown that cyclic glycine-proline (cGP), a metabolite of IGF-1, can normalise IGF-1 function by showing its efficacy in improving the recovery from ischemic brain injury in rats and inhibiting the growth of lymphomic tumours in mice. "

1.	Insulin-Like Growth Factor I (IGF-1)
2.	Insulin-Like Growth Factor Binding Proteins
3.	Adiponectin
4.	Proteins (Proteins, Gene)
5.	Insulin (Novolin)
6.	Insulin-Like Peptides